報告摘要

The global Direct Agglutination Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. North America: the Direct Agglutination Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Direct Agglutination Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Direct Agglutination Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Direct Agglutination Test include Atlas Medical GmbH, Thermo Fisher Scientific, Bio-Rad, HiMedia, Pro Lab, Arlington Scientific, Hardy Diagnostics, Liofilchem S.r.l and Biotec. among others; in 2025, the top three vendors together accounted for approximately % of global revenue. Report Scope This report quantifies the global Direct Agglutination Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032. It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Direct Agglutination Test. Key Companies & Market Share Insights This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking. Direct Agglutination Test Market by Company Atlas Medical GmbH Thermo Fisher Scientific Bio-Rad HiMedia Pro Lab Arlington Scientific Hardy Diagnostics Liofilchem S.r.l Biotec Direct Agglutination Test Segment by Type Blood Urine Escherichia Coli Others Direct Agglutination Test Segment by Application Clinics Hospital Other Direct Agglutination Test Segment by Region North America United States Canada Mexico Europe Germany France U.K. Italy Spain Russia Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Middle East & Africa Saudi Arabia Israel United Arab Emirates Turkey Iran Egypt Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. Reasons to Buy This Report 1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Direct Agglutination Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. 2. This report will help stakeholders to understand the global industry status and trends of Direct Agglutination Test and provides them with information on key market drivers, restraints, challenges, and opportunities. 3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. 4. This report stays updated with novel technology integration, features, and the latest developments in the market 5. This report helps stakeholders to gain insights into which regions to target globally 6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Direct Agglutination Test. 7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Chapter Outline Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Direct Agglutination Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report.

目錄 Table of Contents

1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Direct Agglutination Test by Type 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) 2.2.2 Blood 2.2.3 Urine 2.2.4 Escherichia Coli 2.2.5 Others 2.3 Direct Agglutination Test by Application 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) 2.3.2 Clinics 2.3.3 Hospital 2.3.4 Other 2.4 Assumptions and Limitations 3 Direct Agglutination Test Breakdown Data by Type 3.1 Global Direct Agglutination Test Historic Market Size by Type (2021-2026) 3.2 Global Direct Agglutination Test Forecasted Market Size by Type (2027-2032) 4 Direct Agglutination Test Breakdown Data by Application 4.1 Global Direct Agglutination Test Historic Market Size by Application (2021-2026) 4.2 Global Direct Agglutination Test Forecasted Market Size by Application (2027-2032) 5 Global Growth Trends 5.1 Global Direct Agglutination Test Market Perspective (2021-2032) 5.2 Global Direct Agglutination Test Growth Trends by Region 5.2.1 Global Direct Agglutination Test Market Size by Region: 2021 VS 2025 VS 2032 5.2.2 Direct Agglutination Test Historic Market Size by Region (2021-2026) 5.2.3 Direct Agglutination Test Forecasted Market Size by Region (2027-2032) 5.3 Direct Agglutination Test Market Dynamics 5.3.1 Direct Agglutination Test Industry Trends 5.3.2 Direct Agglutination Test Market Drivers 5.3.3 Direct Agglutination Test Market Challenges 5.3.4 Direct Agglutination Test Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Direct Agglutination Test Players by Revenue 6.1.1 Global Top Direct Agglutination Test Players by Revenue (2021-2026) 6.1.2 Global Direct Agglutination Test Revenue Market Share by Players (2021-2026) 6.2 Global Direct Agglutination Test Industry Players Ranking, 2023 VS 2024 VS 2025 6.3 Global Key Players of Direct Agglutination Test Head Office and Area Served 6.4 Global Direct Agglutination Test Players, Product Type & Application 6.5 Global Direct Agglutination Test Manufacturers Established Date 6.6 Global Direct Agglutination Test Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Direct Agglutination Test Market Size (2021-2032) 7.2 North America Direct Agglutination Test Market Growth Rate by Country: 2021 VS 2025 VS 2032 7.3 North America Direct Agglutination Test Market Size by Country (2021-2026) 7.4 North America Direct Agglutination Test Market Size by Country (2027-2032) 7.5 United States 7.5 United States 7.6 Canada 7.7 Mexico 8 Europe 8.1 Europe Direct Agglutination Test Market Size (2021-2032) 8.2 Europe Direct Agglutination Test Market Growth Rate by Country: 2021 VS 2025 VS 2032 8.3 Europe Direct Agglutination Test Market Size by Country (2021-2026) 8.4 Europe Direct Agglutination Test Market Size by Country (2027-2032) 8.5 Germany 8.6 France 8.7 U.K. 8.8 Italy 8.9 Spain 8.10 Russia 8.11 Netherlands 8.12 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Direct Agglutination Test Market Size (2021-2032) 9.2 Asia-Pacific Direct Agglutination Test Market Growth Rate by Country: 2021 VS 2025 VS 2032 9.3 Asia-Pacific Direct Agglutination Test Market Size by Country (2021-2026) 9.4 Asia-Pacific Direct Agglutination Test Market Size by Country (2027-2032) 9.5 China 9.6 Japan 9.7 South Korea 9.8 India 9.9 Australia 9.10 China Taiwan 9.11 Southeast Asia 10 South America 10.1 South America Direct Agglutination Test Market Size (2021-2032) 10.2 South America Direct Agglutination Test Market Growth Rate by Country: 2021 VS 2025 VS 2032 10.3 South America Direct Agglutination Test Market Size by Country (2021-2026) 10.4 South America Direct Agglutination Test Market Size by Country (2027-2032) 10.5 Brazil 10.6 Argentina 10.7 Chile 10.8 Colombia 10.9 Peru 11 Middle East & Africa 11.1 Middle East & Africa Direct Agglutination Test Market Size (2021-2032) 11.2 Middle East & Africa Direct Agglutination Test Market Growth Rate by Country: 2021 VS 2025 VS 2032 11.3 Middle East & Africa Direct Agglutination Test Market Size by Country (2021-2026) 11.4 Middle East & Africa Direct Agglutination Test Market Size by Country (2027-2032) 11.5 Saudi Arabia 11.6 Israel 11.7 United Arab Emirates 11.8 Turkey 11.9 Iran 11.10 Egypt 12 Players Profiled 12.1 Atlas Medical GmbH 12.1.1 Atlas Medical GmbH Company Information 12.1.2 Atlas Medical GmbH Business Overview 12.1.3 Atlas Medical GmbH Revenue in Direct Agglutination Test Business (2021-2026) 12.1.4 Atlas Medical GmbH Direct Agglutination Test Product Portfolio 12.1.5 Atlas Medical GmbH Recent Developments 12.2 Thermo Fisher Scientific 12.2.1 Thermo Fisher Scientific Company Information 12.2.2 Thermo Fisher Scientific Business Overview 12.2.3 Thermo Fisher Scientific Revenue in Direct Agglutination Test Business (2021-2026) 12.2.4 Thermo Fisher Scientific Direct Agglutination Test Product Portfolio 12.2.5 Thermo Fisher Scientific Recent Developments 12.3 Bio-Rad 12.3.1 Bio-Rad Company Information 12.3.2 Bio-Rad Business Overview 12.3.3 Bio-Rad Revenue in Direct Agglutination Test Business (2021-2026) 12.3.4 Bio-Rad Direct Agglutination Test Product Portfolio 12.3.5 Bio-Rad Recent Developments 12.4 HiMedia 12.4.1 HiMedia Company Information 12.4.2 HiMedia Business Overview 12.4.3 HiMedia Revenue in Direct Agglutination Test Business (2021-2026) 12.4.4 HiMedia Direct Agglutination Test Product Portfolio 12.4.5 HiMedia Recent Developments 12.5 Pro Lab 12.5.1 Pro Lab Company Information 12.5.2 Pro Lab Business Overview 12.5.3 Pro Lab Revenue in Direct Agglutination Test Business (2021-2026) 12.5.4 Pro Lab Direct Agglutination Test Product Portfolio 12.5.5 Pro Lab Recent Developments 12.6 Arlington Scientific 12.6.1 Arlington Scientific Company Information 12.6.2 Arlington Scientific Business Overview 12.6.3 Arlington Scientific Revenue in Direct Agglutination Test Business (2021-2026) 12.6.4 Arlington Scientific Direct Agglutination Test Product Portfolio 12.6.5 Arlington Scientific Recent Developments 12.7 Hardy Diagnostics 12.7.1 Hardy Diagnostics Company Information 12.7.2 Hardy Diagnostics Business Overview 12.7.3 Hardy Diagnostics Revenue in Direct Agglutination Test Business (2021-2026) 12.7.4 Hardy Diagnostics Direct Agglutination Test Product Portfolio 12.7.5 Hardy Diagnostics Recent Developments 12.8 Liofilchem S.r.l 12.8.1 Liofilchem S.r.l Company Information 12.8.2 Liofilchem S.r.l Business Overview 12.8.3 Liofilchem S.r.l Revenue in Direct Agglutination Test Business (2021-2026) 12.8.4 Liofilchem S.r.l Direct Agglutination Test Product Portfolio 12.8.5 Liofilchem S.r.l Recent Developments 12.9 Biotec 12.9.1 Biotec Company Information 12.9.2 Biotec Business Overview 12.9.3 Biotec Revenue in Direct Agglutination Test Business (2021-2026) 12.9.4 Biotec Direct Agglutination Test Product Portfolio 12.9.5 Biotec Recent Developments 13 Report Conclusion 14 Disclaimer

圖表清單 List of Tables & Figures

List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Direct Agglutination Test Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Direct Agglutination Test Revenue Market Share by Type (2021-2026) Table 7. Global Direct Agglutination Test Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Direct Agglutination Test Revenue Market Share by Type (2027-2032) Table 9. Global Direct Agglutination Test Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Direct Agglutination Test Revenue Market Share by Application (2021-2026) Table 11. Global Direct Agglutination Test Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Direct Agglutination Test Revenue Market Share by Application (2027-2032) Table 13. Global Direct Agglutination Test Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Direct Agglutination Test Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Direct Agglutination Test Market Share by Region (2021-2026) Table 16. Global Direct Agglutination Test Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Direct Agglutination Test Market Share by Region (2027-2032) Table 18. Direct Agglutination Test Industry Trends Table 19. Direct Agglutination Test Industry Drivers Table 20. Direct Agglutination Test Industry Opportunities and Challenges Table 21. Direct Agglutination Test Market Restraints Table 22. Global Top Direct Agglutination Test Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Direct Agglutination Test Revenue Market Share by Players (2021-2026) Table 24. Global Direct Agglutination Test Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Direct Agglutination Test, Headquarters and Area Served Table 26. Global Direct Agglutination Test Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Direct Agglutination Test by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Direct Agglutination Test Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Direct Agglutination Test Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Direct Agglutination Test Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Direct Agglutination Test Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Direct Agglutination Test Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Direct Agglutination Test Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Direct Agglutination Test Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Direct Agglutination Test Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Direct Agglutination Test Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Direct Agglutination Test Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Direct Agglutination Test Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Direct Agglutination Test Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Direct Agglutination Test Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Direct Agglutination Test Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Direct Agglutination Test Market Size by Country (2027-2032) & (US$ Million) Table 45. Atlas Medical GmbH Company Information Table 46. Atlas Medical GmbH Business Overview Table 47. Atlas Medical GmbH Revenue in Direct Agglutination Test Business (2021-2026) & (US$ Million) Table 48. Atlas Medical GmbH Direct Agglutination Test Product Portfolio Table 49. Atlas Medical GmbH Recent Developments Table 50. Thermo Fisher Scientific Company Information Table 51. Thermo Fisher Scientific Business Overview Table 52. Thermo Fisher Scientific Revenue in Direct Agglutination Test Business (2021-2026) & (US$ Million) Table 53. Thermo Fisher Scientific Direct Agglutination Test Product Portfolio Table 54. Thermo Fisher Scientific Recent Developments Table 55. Bio-Rad Company Information Table 56. Bio-Rad Business Overview Table 57. Bio-Rad Revenue in Direct Agglutination Test Business (2021-2026) & (US$ Million) Table 58. Bio-Rad Direct Agglutination Test Product Portfolio Table 59. Bio-Rad Recent Developments Table 60. HiMedia Company Information Table 61. HiMedia Business Overview Table 62. HiMedia Revenue in Direct Agglutination Test Business (2021-2026) & (US$ Million) Table 63. HiMedia Direct Agglutination Test Product Portfolio Table 64. HiMedia Recent Developments Table 65. Pro Lab Company Information Table 66. Pro Lab Business Overview Table 67. Pro Lab Revenue in Direct Agglutination Test Business (2021-2026) & (US$ Million) Table 68. Pro Lab Direct Agglutination Test Product Portfolio Table 69. Pro Lab Recent Developments Table 70. Arlington Scientific Company Information Table 71. Arlington Scientific Business Overview Table 72. Arlington Scientific Revenue in Direct Agglutination Test Business (2021-2026) & (US$ Million) Table 73. Arlington Scientific Direct Agglutination Test Product Portfolio Table 74. Arlington Scientific Recent Developments Table 75. Hardy Diagnostics Company Information Table 76. Hardy Diagnostics Business Overview Table 77. Hardy Diagnostics Revenue in Direct Agglutination Test Business (2021-2026) & (US$ Million) Table 78. Hardy Diagnostics Direct Agglutination Test Product Portfolio Table 79. Hardy Diagnostics Recent Developments Table 80. Liofilchem S.r.l Company Information Table 81. Liofilchem S.r.l Business Overview Table 82. Liofilchem S.r.l Revenue in Direct Agglutination Test Business (2021-2026) & (US$ Million) Table 83. Liofilchem S.r.l Direct Agglutination Test Product Portfolio Table 84. Liofilchem S.r.l Recent Developments Table 85. Biotec Company Information Table 86. Biotec Business Overview Table 87. Biotec Revenue in Direct Agglutination Test Business (2021-2026) & (US$ Million) Table 88. Biotec Direct Agglutination Test Product Portfolio Table 89. Biotec Recent Developments Table 90. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Direct Agglutination Test Product Image Figure 5. Global Direct Agglutination Test Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Direct Agglutination Test Market Share by Type: 2025 VS 2032 Figure 7. Blood Product Figure 8. Urine Product Figure 9. Escherichia Coli Product Figure 10. Others Product Figure 11. Global Direct Agglutination Test Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Direct Agglutination Test Market Share by Application: 2025 VS 2032 Figure 13. Clinics Product Figure 14. Hospital Product Figure 15. Other Product Figure 16. Global Direct Agglutination Test Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Direct Agglutination Test Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Direct Agglutination Test Market Share by Region: 2025 VS 2032 Figure 19. Global Direct Agglutination Test Market Share by Players in 2025 Figure 20. Global Direct Agglutination Test Manufacturers Established Date Figure 21. Global Top 5 and 10 Direct Agglutination Test Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Direct Agglutination Test Market Share by Country (2021-2032) Figure 25. United States Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Direct Agglutination Test Market Share by Country (2021-2032) Figure 28. Europe Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Direct Agglutination Test Market Share by Country (2021-2032) Figure 30. Germany Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Direct Agglutination Test Market Share by Country (2021-2032) Figure 40. China Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Direct Agglutination Test Market Share by Country (2021-2032) Figure 45. Australia Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Direct Agglutination Test Market Share by Country (2021-2032) Figure 50. Brazil Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Direct Agglutination Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Atlas Medical GmbH Revenue Growth Rate in Direct Agglutination Test Business (2021-2026) Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Direct Agglutination Test Business (2021-2026) Figure 57. Bio-Rad Revenue Growth Rate in Direct Agglutination Test Business (2021-2026) Figure 58. HiMedia Revenue Growth Rate in Direct Agglutination Test Business (2021-2026) Figure 59. Pro Lab Revenue Growth Rate in Direct Agglutination Test Business (2021-2026) Figure 60. Arlington Scientific Revenue Growth Rate in Direct Agglutination Test Business (2021-2026) Figure 61. Hardy Diagnostics Revenue Growth Rate in Direct Agglutination Test Business (2021-2026) Figure 62. Liofilchem S.r.l Revenue Growth Rate in Direct Agglutination Test Business (2021-2026) Figure 63. Biotec Revenue Growth Rate in Direct Agglutination Test Business (2021-2026)

Single User	$2,950 USD
Multi User	$4,430 USD
Enterprise	$5,900 USD

Direct Agglutination Test Industry Research Report 2026

授權報價

報告摘要

提及公司